Record 2025 revenue rose 13% year-over-year, with core business and EBITDA margins exceeding 48%. One-off impairment charges impacted reported net profit, but strong Q4 results and major investments support continued growth.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.